Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3131682

CCCCCCCCCCCCCCCCC(c1ccccc1)[N+](C)(C)CCCCCCCCCCCCCCCC.[Cl-]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.42
CHRM1 known ✓ P11229 1/20 0.42
CHRM3 known ✓ P20309 1/20 0.42
SLC6A2 known ✓ P23975 1/20 0.42
SLC6A3 known ✓ Q01959 1/20 0.42
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPK1 P28482 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TP53 P04637 1/20 0.49
HTT P42858 3/20 0.47
DNM1 Q05193 3/20 0.46
HTR2A P28223 2/20 0.42
OPRK1 P41145 2/20 0.42
MLNR O43193 1/20 0.42
NR1I2 O75469 1/20 0.42
ESR1 P03372 1/20 0.42
NR3C1 P04150 1/20 0.42
PGR P06401 1/20 0.42
ADRB2 P07550 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2123138 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL9154692 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL6892150 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL9311863 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL6894372 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL9173529 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL1134616 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL10361962 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL2812471 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53
Hydrochloric Acid SCHEMBL27992053 1.00 MEN1 (0.49) MEN1KMT2AMAPK1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027020-A1 SELF-CURING ACRYLIC COMPOSITION FOR HAIR STYLING EasyFix Hair Design LTD. (IL) 2026-01-29 US disclosed
EP-3145476-B1 CONSUMER PRODUCTS PROCTER & GAMBLE (US) 2025-07-09 EP disclosed
US-20240238180-A1 SELF-CURING ACRYLIC FORMULATIONS CONTAINING N-ACETYL CYSTEINE FOR HAIR STRAIGHTENING EASY FIX HAIR DESIGN LTD. (IL) 2024-07-18 US disclosed
EP-4319596-A1 SELF-CURING ACRYLIC FORMULATIONS CONTAINING N-ACETYL CYSTEINE FOR HAIR STRAIGHTENING EasyFix Hair Design Ltd. (IL) 2024-02-14 EP disclosed
WO-2022215069-A1 SELF-CURING ACRYLIC FORMULATIONS CONTAINING N-ACETYL CYSTEINE FOR HAIR STRAIGHTENING EasyFix Hair Design LTD. (IL) 2022-10-13 WO disclosed
US-20210212918-A1 SELF-CURING ACRYLIC COMPOSITION FOR HAIR STYLING EasyFix Hair Design LTD. (IL) 2021-07-15 US disclosed
EP-3801775-A1 SELF-CURING ACRYLIC COMPOSITION FOR HAIR STYLING EasyFix Hair Design Ltd. (IL) 2021-04-14 EP disclosed
US-9937111-B2 Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating THE PROCTER & GAMBLE COMPANY (US) 2018-04-10 US disclosed
US-9877899-B2 Consumer product comprising a fibrous web structure with a silicone conditioning agent coating THE PROCTER & GAMBLE COMPANY (US) 2018-01-30 US disclosed
US-9867762-B2 Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating THE PROCTER & GAMBLE COMPANY (US) 2018-01-16 US disclosed
US-20030223946-A1 Durable fiber treatment composition THE PROCTER & GAMBLE COMPANY 2003-12-04 US disclosed
US-20030211953-A1 Durable fiber treatment composition THE PROCTER & GAMBLE COMPANY 2003-11-13 US disclosed
WO-2003090510-A2 DURABLE HAIR TREATMENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2003-11-06 WO disclosed
WO-2003090508-A2 DURABLE FIBER TREATMENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2003-11-06 WO disclosed
EP-1358864-A2 Durable fiber treatment composition THE PROCTER & GAMBLE COMPANY (US) 2003-11-05 EP disclosed
EP-1356800-A2 Durable fiber treatment composition THE PROCTER & GAMBLE COMPANY (US) 2003-10-29 EP disclosed
US-20020192173-A1 Anhydrous treatment compositions for the delivery of reactive agents to amino-acid based substrates THE PROCTER & GAMBLE COMPANY 2002-12-19 US disclosed
US-20020155080-A1 Delivery of reactive agents via multiple emulsions for use in shelf stable products PROCTER & GAMBLE COMPANY, THE 2002-10-24 US disclosed
US-20020131945-A1 Delivery of reactive agents via self emulsification for use in shelf-stable products PROCTER & GAMBLE COMPANY, THE 2002-09-19 US disclosed
WO-2002069917-A2 DELIVERY OF REACTIVE AGENTS VIA MULTIPLE EMULSIONS FOR USE IN SHELF STABLE PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2002-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030223946-A1 Durable fiber treatment composition KRT18, PLOD3, HDAC7 CHRM2 1166/4885CHRM1 1770/4885CHRM3 1696/4885
US-20260027020-A1 SELF-CURING ACRYLIC COMPOSITION FOR HAIR STYLING SUCLG1, PLOD3, ASS1 CHRM2 1121/4885CHRM1 1197/4885CHRM3 2238/4885
US-20020192173-A1 Anhydrous treatment compositions for the delivery of reactive agents to amino-acid based substrates AADAT, SLC38A7, DNPEP CHRM2 2601/4885CHRM1 3218/4885CHRM3 2943/4885
US-20020131945-A1 Delivery of reactive agents via self emulsification for use in shelf-stable products LPO, GPX4, CAT CHRM2 4187/4885CHRM1 3744/4885CHRM3 4686/4885
US-20020155080-A1 Delivery of reactive agents via multiple emulsions for use in shelf stable products POLR1C, IMMT, NACA CHRM2 4725/4885CHRM1 4748/4885CHRM3 4778/4885
US-20030211953-A1 Durable fiber treatment composition KRT18, HDAC7, PLOD3 CHRM2 1601/4885CHRM1 2330/4885CHRM3 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.